[1]
2025. Assessing the Quality of Life and Survival of Iraqi Patients with Metastatic Colorectal Cancer Receiving Bevacizumab   and Chemotherapy. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 4 (Oct. 2025), 476–492. DOI:https://doi.org/10.32947/ajps.v25i4.1218.